课题基金 / 基金详情

Plasma lipidomic signatures for risk prediction and prevention of gestational diabetes

Plasma lipidomic signatures for risk prediction and prevention of gestational diabetes
用于妊娠期糖尿病风险预测和预防的血浆脂质组学特征
批准号:
nhmrc : GNT1161871
负责人:
Dr Aya Mousa
金额:
$32.72万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Early Career Fellowships
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Over 20,000 Australian women develop gestational diabetes (GDM) annually, increasing their risk of pregnancy complications, as well as diabetes and heart disease later in life. Lipids are a key source of energy for cells and often change during pregnancy, yet their role in GDM is unknown. Using novel techniques, I will measure hundreds of lipids to examine whether certain lipid species contribute to GDM development and whether these lipids are altered by diet, lifestyle, and/or drug therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金